{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:29:51Z","timestamp":1789878591599,"version":"4.0.1"},"reference-count":41,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>AMP-activated protein kinase (AMPK) inhibits IGF-I actions, but the mechanism by which AMPK functions is undefined. This study identified signaling events that were induced by AMPK that mediated inhibition of IGF-I-stimulated phosphoinosotide-3-kinase (PI3K) pathway activation. The AMPK activator metformin stimulated AMPK Thr172 phosphorylation and inhibited IGF-I-stimulated phosphorylation of Akt\/tuberous sclerosis 2 (TSC2)\/mammalian target of rapamycin (mTOR)\/p70S6 kinase (p70S6K). Expression of constitutively active forms of AMPK suppressed IGF-I-stimulated activation of Akt\/TSC2\/mTOR\/p70S6K and protein synthesis, whereas AMPK knockdown resulted in enhanced responses to IGF-I. To determine the mechanism by which AMPK inhibited IGF-I signaling, the role of insulin receptor substrate-1 (IRS-1) was examined. Both metformin and constitutively activated AMPK enhanced phosphorylation of IRS-1 Ser794, which led to decreased IRS-1 tyrosine phosphorylation and recruitment of the p85 subunit of PI3K. Overexpression of IRS-1 S794A was associated with increased IGF-I-stimulated IRS-1 tyrosine phosphorylation, p85 association, and protein synthesis. To determine whether other signaling molecules mediated the effect of AMPK, TSC2 function was examined. Cells overexpressing TSC2\/S1345A (the site of AMPK phosphorylation) were less responsive to metformin-induced inhibition of p70S6 kinase. These findings are relevant to whole animal physiology because administration of metformin to mice resulted in inhibition of IGF-I-stimulated phosphorylation of Akt\/mTOR\/p70S6K. In conclusion, AMPK functions to inhibit IGF-I-stimulated PI3K pathway activation through stimulation of IRS-1 serine 794 phosphorylation. Because IGF-I is an important stimulant of the anabolic response, this effect of AMPK could account for part of its inhibitory effect on protein synthesis, thus allowing more efficient energy use by other cellular processes.<\/jats:p>","DOI":"10.1210\/me.2009-0474","type":"journal-article","created":{"date-parts":[[2010,4,5]],"date-time":"2010-04-05T17:44:28Z","timestamp":1270489468000},"page":"1218-1229","source":"Crossref","is-referenced-by-count":77,"title":["AMP-Activated Protein Kinase Inhibits IGF-I Signaling and Protein Synthesis in Vascular Smooth Muscle Cells via Stimulation of Insulin Receptor Substrate 1 S794 and Tuberous Sclerosis 2 S1345 Phosphorylation"],"prefix":"10.1210","volume":"24","author":[{"given":"Junyu","family":"Ning","sequence":"first","affiliation":[{"name":"Department of Medicine, University of North Carolina, School of Medicine, Chapel Hill, North Carolina 27705"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Clemmons","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of North Carolina, School of Medicine, Chapel Hill, North Carolina 27705"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614102838400_R1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tibs.2003.11.005","article-title":"The AMP-activated protein kinase cascade: a unifying system for energy control.","volume":"29","author":"Carling","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"2020071614102838400_R2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1432-1033.1997.00259.x","article-title":"The AMP-activated protein kinase: fuel gauge of the mammalian cell?","volume":"246","author":"Hardie","year":"1997","journal-title":"Eur J Biochem"},{"key":"2020071614102838400_R3","doi-asserted-by":"crossref","first-page":"27879","DOI":"10.1074\/jbc.271.44.27879","article-title":"Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase.","volume":"271","author":"Hawley","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071614102838400_R4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.biochem.67.1.821","article-title":"The AMP-activated\/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?","volume":"67","author":"Hardie","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"2020071614102838400_R5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0960-9822(00)00070-1","article-title":"Role of the AMP-activated protein kinase in the cellular stress response.","volume":"4","author":"Corton","year":"1994","journal-title":"Curr Biol"},{"key":"2020071614102838400_R6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease.","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat Genet"},{"key":"2020071614102838400_R7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat Cell Biol"},{"key":"2020071614102838400_R8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibs.2003.11.007","article-title":"TSC2: filling the GAP in the mTOR signaling pathway.","volume":"29","author":"Li","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"2020071614102838400_R9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ncb840","article-title":"Akt regulates growth by directly phosphorylating Tsc2.","volume":"4","author":"Potter","year":"2002","journal-title":"Nat Cell Biol"},{"key":"2020071614102838400_R10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival.","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"2020071614102838400_R11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s.","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"2020071614102838400_R12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/01.RES.86.2.125","article-title":"The insulin-like growth factor axis: a review of atherosclerosis and restenosis.","volume":"86","author":"Bayes-Genis","year":"2000","journal-title":"Circ Res"},{"key":"2020071614102838400_R13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd2359","article-title":"Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer.","volume":"6","author":"Clemmons","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"2020071614102838400_R14","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.biocel.2005.04.018","article-title":"Skeletal muscle hypertrophy and atrophy signaling pathways.","volume":"37","author":"Glass","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"2020071614102838400_R15","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbrc.2006.02.088","article-title":"AMPK activation inhibits the expression of HIF-1\u03b1 induced by insulin and IGF-1.","volume":"342","author":"Treins","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071614102838400_R16","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1158\/0008-5472.CAN-05-3111","article-title":"Thiazolidinediones inhibit insulin-like growth factor-I-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity.","volume":"66","author":"He","year":"2006","journal-title":"Cancer Res"},{"key":"2020071614102838400_R17","doi-asserted-by":"crossref","first-page":"46912","DOI":"10.1074\/jbc.C100483200","article-title":"5\u2032-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside.","volume":"276","author":"Jakobsen","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071614102838400_R18","doi-asserted-by":"crossref","first-page":"18440","DOI":"10.1074\/jbc.M211770200","article-title":"Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2.","volume":"278","author":"Horike","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071614102838400_R19","doi-asserted-by":"crossref","first-page":"18069","DOI":"10.1074\/jbc.M610101200","article-title":"Energy depletion inhibits phosphatidylinositol 3-kinase\/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794.","volume":"282","author":"Tzatsos","year":"2007","journal-title":"J Biol Chem"},{"key":"2020071614102838400_R20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1139\/y04-107","article-title":"Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy.","volume":"83","author":"Chan","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"key":"2020071614102838400_R21","doi-asserted-by":"crossref","first-page":"19102","DOI":"10.1074\/jbc.M011579200","article-title":"Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway.","volume":"276","author":"Kim","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071614102838400_R22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejphar.2008.06.034","article-title":"Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.","volume":"590","author":"Liang","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"2020071614102838400_R23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"2020071614102838400_R24","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1210\/me.2008-0265","article-title":"Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.","volume":"22","author":"Kim","year":"2008","journal-title":"Mol Endocrinol"},{"key":"2020071614102838400_R25","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1074\/jbc.M407517200","article-title":"Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin (PI3K\/Akt\/mTOR) pathway.","volume":"280","author":"Latres","year":"2005","journal-title":"J Biol Chem"},{"key":"2020071614102838400_R26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/mend.12.1.0047","article-title":"Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells.","volume":"12","author":"Kaliman","year":"1998","journal-title":"Mol Endocrinol"},{"key":"2020071614102838400_R27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev-genet-102108-134815","article-title":"Regulation of tissue growth through nutrient sensing.","volume":"43","author":"Hietakangas","year":"2009","journal-title":"Annu Rev Genet"},{"key":"2020071614102838400_R28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2478\/s11658-009-0033-1","article-title":"Treatment with TNF-\u03b1 and IFN-\u03b3 alters the activation of SER\/THR protein kinases and the metabolic response to IGF-I in mouse c2c12 myogenic cells.","volume":"15","author":"Grzelkowska-Kowalczyk","year":"2010","journal-title":"Cell Mol Biol Lett"},{"key":"2020071614102838400_R29","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1210\/endo.141.8.7621","article-title":"Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis.","volume":"141","author":"Singleton","year":"2000","journal-title":"Endocrinology"},{"key":"2020071614102838400_R30","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1096\/fj.07-094144","article-title":"AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing\u2019s syndrome.","volume":"22","author":"Christ-Crain","year":"2008","journal-title":"FASEB J"},{"key":"2020071614102838400_R31","doi-asserted-by":"crossref","first-page":"27952","DOI":"10.1074\/jbc.M109.046292","article-title":"AMP-activated protein kinase mediates the interferon-\u03b3-induced decrease in intestinal epithelial barrier function.","volume":"284","author":"Scharl","year":"2009","journal-title":"J Biol Chem"},{"key":"2020071614102838400_R32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0895-7061(03)00059-1","article-title":"Altered insulin-like growth factor-1 and nitric oxide sensitivities in hypertension contribute to vascular hyperplasia.","volume":"16","author":"Nolan","year":"2003","journal-title":"Am J Hypertens"},{"key":"2020071614102838400_R33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/endo.142.2.7941","article-title":"Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractility.","volume":"142","author":"Zhao","year":"2001","journal-title":"Endocrinology"},{"key":"2020071614102838400_R34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2265.2001.01256.x","article-title":"Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly.","volume":"54","author":"Colao","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614102838400_R35","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1210\/en.2005-0888","article-title":"Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-\u03baB.","volume":"147","author":"Ma","year":"2006","journal-title":"Endocrinology"},{"key":"2020071614102838400_R36","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1210\/en.2004-0029","article-title":"Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase.","volume":"145","author":"Zahradka","year":"2004","journal-title":"Endocrinology"},{"key":"2020071614102838400_R37","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1210\/en.2007-0285","article-title":"Differential regulation of hypoxia-inducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cells.","volume":"148","author":"Lauzier","year":"2007","journal-title":"Endocrinology"},{"key":"2020071614102838400_R38","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1210\/endo.136.10.7545099","article-title":"Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II.","volume":"136","author":"Gockerman","year":"1995","journal-title":"Endocrinology"},{"key":"2020071614102838400_R39","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1210\/me.2008-0079","article-title":"p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.","volume":"22","author":"Xi","year":"2008","journal-title":"Mol Endocrinol"},{"key":"2020071614102838400_R40","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1091\/mbc.e04-10-0918","article-title":"Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.","volume":"16","author":"Ling","year":"2005","journal-title":"Mol Biol Cell"},{"key":"2020071614102838400_R41","doi-asserted-by":"crossref","first-page":"11217","DOI":"10.1073\/pnas.95.19.11217","article-title":"Blocking ligand occupancy of the \u03b1V\u03b23 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells.","volume":"95","author":"Zheng","year":"1998","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/24\/6\/1218\/8944678\/mend1218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/24\/6\/1218\/8944678\/mend1218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:33:50Z","timestamp":1594949630000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/24\/6\/1218\/2706158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2009-0474","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,1]]}}}